INVITAE
Invitae is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare for billions of people. Specializing in genetic diagnostics for hereditary disorders, Invitae is aggregating the worldโs genetic tests into a single service with better quality, faster turnaround time, and a lower price than most single-gene diagnostic tests today. Whatโs our plan? It takes three steps: --Make genetic testing more ... affordable and accessible than ever before. --Build a secure and trusted genome management infrastructure. --Design a new global community for sharing genetic information to advance science and medicine. Today, we are reinventing genetic testing by lowering the barriers for clinicians and patients to obtain diagnostic genetic information. Together we can improve healthcare for billions of people.
INVITAE
Industry:
Biotechnology Genetics Health Care
Founded:
2010-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.invitae.com
Total Employee:
501+
Status:
Active
Contact:
+1 (415) 930-4018
Email Addresses:
[email protected]
Total Funding:
1.99 B USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Domain Not Resolving Global Site Tag Mobile Non Scaleable Content
Similar Organizations
Alector
Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel.
Aperiomics
Advancing healthcare and revolutionizing infection testing for improved global health
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Fulcrum Therapeutics
Fulcrum Therapeutics is a biotechnology company that develops new medicines to treat patients with rare genetic diseases.
Generation Bio
Generation Bio develops a breakthrough class of genetic medicines based on its proprietary GeneWave technology.
Helix
Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
Inivata
Inivata is a clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis.
Veritas Genetics
Veritas Genetics is a provider of a genetic testing platform intended to empower people to live healthier and longer.
Voyager Therapeutics
Voyager Therapeutics is a gene therapy company developing treatments for fatal and debilitating diseases of the central nervous system
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2021-09-07 | Ciitizen | Ciitizen acquired by Invitae | 325 M USD |
2021-04-05 | Genosity | Genosity acquired by Invitae | 200 M USD |
2021-02-19 | One Codex | One Codex acquired by Invitae | N/A |
2020-06-22 | ArcherDX | ArcherDX acquired by Invitae | 1.4 B USD |
2020-03-10 | Diploid | Diploid acquired by Invitae | 95 M USD |
2020-03-10 | Genelex | Genelex acquired by Invitae | 20.7 M USD |
2020-03-10 | YouScript | YouScript acquired by Invitae | 79.3 M USD |
2019-11-11 | Clear Genetics | Clear Genetics acquired by Invitae | N/A |
2019-07-11 | Jungla | Jungla acquired by Invitae | 50 M USD |
2019-01-17 | Singular Bio | Singular Bio acquired by Invitae | N/A |
Investors List
SoftBank
SoftBank investment in Post-IPO Debt - Invitae
Decheng Capital
Decheng Capital investment in Series F - Invitae
Deerfield Capital Management
Deerfield Capital Management investment in Series F - Invitae
Redmile Group
Redmile Group investment in Series F - Invitae
Three Leaf Ventures
Three Leaf Ventures investment in Series F - Invitae
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Series F - Invitae
Sofinnova Investments
Sofinnova Investments investment in Series F - Invitae
OrbiMed
OrbiMed investment in Series F - Invitae
J.P. Morgan Securities Inc.
J.P. Morgan Securities Inc. investment in Series F - Invitae
Genomic Health
Genomic Health investment in Series F - Invitae
Official Site Inspections
http://www.invitae.com Semrush global rank: 105.67 K Semrush visits lastest month: 923.54 K
- Host name: ec2-54-144-127-187.compute-1.amazonaws.com
- IP address: 54.144.127.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149